Last reviewed · How we verify
Liquid 13-Cis Retinoic Acid — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Liquid 13-Cis Retinoic Acid (Liquid 13-Cis Retinoic Acid) — Nova Laboratories Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Liquid 13-Cis Retinoic Acid TARGET | Liquid 13-Cis Retinoic Acid | Nova Laboratories Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Liquid 13-Cis Retinoic Acid CI watch — RSS
- Liquid 13-Cis Retinoic Acid CI watch — Atom
- Liquid 13-Cis Retinoic Acid CI watch — JSON
- Liquid 13-Cis Retinoic Acid alone — RSS
Cite this brief
Drug Landscape (2026). Liquid 13-Cis Retinoic Acid — Competitive Intelligence Brief. https://druglandscape.com/ci/liquid-13-cis-retinoic-acid. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab